Study says no to glucose monitoring

Yet more evidence has emerged to question the value of routine self-monitoring of blood glucose (SMBG) in patients with non-insulin-treated type 2 diabetes mellitus (T2DM).

A year-long randomised trial, across 15 primary care practices including 450 patients, found there was no difference in glycaemic control or health-related quality of life between patients who performed SMBG and those who did not.

These findings align with earlier studies that reinforce the limited utility of SMBG in patients with non-insulin-treated T2DM.

Yet the authors note that SMBG has remained a